Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease

JACC: Cardiovascular Interventions

Volumn 6, Issue 4, 2013, Pages 344-354

  MacK, Michael J ^a   Head, Stuart J ^b   Holmes Jr , David R ^c   Ståhle, Elisabeth ^d   Feldman, Ted E ^e   Colombo, Antonio ^f   Morice, Marie Claude ^g   Unger, Felix ^h   Erglis, Andrejs ⁱ   Stoler, Robert ^j   Dawkins, Keith D ^k   Serruys, Patrick W ^b   Mohr, Friedrich W ^l   Kappetein, A Pieter ^b  

^a The Heart Hospital   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAYO CLINIC   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e EVANSTON HOSPITAL   (United States)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^h University Klinik für Herzchirurgie   (Austria)

ⁱ PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^j BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

^l UNIVERSITY OF LEIPZIG   (Germany)

more..

Author keywords

coronary artery bypass graft; drug eluting stent(s); percutaneous coronary intervention; stroke; SYNTAX; Taxus

Indexed keywords

AGED; ARTICLE; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG ELUTING STENT; EUROPE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; EUROPE; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84876407034     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.11.010     Document Type: Article

References (40)

1. The BARI Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
2. P.W. Serruys, A.T.L. Ong, L.A. van Herwerden Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
3. P.W. Serruys, Y. Onuma, S. Garg ARTS II Investigators 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
4. A. Kapur, R.J. Hall, I.S. Malik Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440
5. P.W. Serruys, M.C. Morice, A.P. Kappetein SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
6. M.S. Lee, F. Jamal, G. Kedia Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease Int J Cardiol 123 2007 34 42
7. M.S. Lee, N. Kapoor, F. Jamal Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 47 2006 864 870
8. M.A. Hlatky, D.B. Boothroyd, D.M. Bravata Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet 373 2009 1190 1197
9. S.J. Head, A.J. Bogers, P.W. Serruys, J.J. Takkenberg, A.P. Kappetein A crucial factor in shared decision making: the team approach Lancet 377 2011 1836
10. S.J. Head, D.R. Holmes Jr., M.J. Mack SYNTAX Investigators Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries J Am Coll Cardiol Intv 5 2012 618 625
11. A.T. Ong, P.W. Serruys, F.W. Mohr The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase Am Heart J 151 2006 1194 1204
12. A.P. Kappetein, T.E. Feldman, M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
13. E.L. Hannan, C. Wu, G. Walford Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease N Engl J Med 358 2008 331 341
14. The BARI Investigators The final 10-year follow-up results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
15. W.S. Weintraub, M.V. Grau-Sepulveda, J.M. Weiss Comparative effectiveness of revascularization strategies N Engl J Med 366 2012 1467 1476
16. D.J. Cohen, B. Van Hout, P.W. Serruys SYNTAX Investigators Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery N Engl J Med 364 2011 1016 1026
17. K.G. Tarakji, J.F. Sabik 3rd, S.K. Bhudia, L.H. Batizy, E.H. Blackstone Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting JAMA 305 2011 381 390
18. J. Bucerius, J.F. Gummert, M.A. Borger Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients Ann Thorac Surg 75 2003 472 478
19. A. Chieffo, N. Morici, F. Maisano Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience Circulation 113 2006 2542 2547
20. A. Javaid, D.H. Steinberg, A.N. Buch Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease Circulation 116 Suppl 11 2007 I200 I206
21. M. Sanmartín, J.A. Baz, R. Claro Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease Am J Cardiol 100 2007 970 973
22. J. Daemen, E. Boersma, M. Flather Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation 118 2008 1146 1154
23. M.E. Farkouh, M. Domanski, L.A. Sleeper FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
24. O. Kuss, B. von Salviati, J. Börgermann Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses J Thorac Cardiovasc Surg 140 2010 829 835 835.e1-13
25. S.J. Head, A.P. Kappetein Off-pump or on-pump coronary-artery bypass grafting N Engl J Med 367 2012 577 578
26. R. Sharony, C.S. Bizekis, M. Kanchuger Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: a case control study Circulation 108 Suppl 1 2003 II15 II20
27. M.F. El-Chami, P. Kilgo, V. Thourani New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft J Am Coll Cardiol 55 2010 1370 1376
28. M. Ambrosetti, R. Tramarin, R. Griffo ISYDE and ICAROS Investigators of IACPR-GICR Late postoperative atrial fibrillation after cardiac surgery: a national survey within the cardiac rehabilitation setting J Cardiovasc Med (Hagerstown) 12 2011 390 395
29. S.J. Hoffman, D.R. Holmes Jr., A.A. Rabinstein Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience J Am Coll Cardiol Intv 4 2011 415 422
30. V. Rao, G.T. Christakis, R.D. Weisel Risk factors for stroke following coronary bypass surgery J Card Surg 10 Suppl 4 1995 468 474
31. A.L. Doonan, J. Karha, T.P. Carrigan Presence of carotid and peripheral arterial disease in patients with left main disease Am J Cardiol 100 2007 1087 1089
32. W.T. Vigneswaran, R.N. Sapsford, R.D. Stanbridge Disease of the left main coronary artery: early surgical results and their association with carotid artery stenosis Br Heart J 70 1993 342 345
33. A. Aggarwal, D. Dai, J.S. Rumsfeld American College of Cardiology National Cardiovascular Data Registry Incidence and predictors of stroke associated with percutaneous coronary intervention Am J Cardiol 104 2009 349 353
34. S. Dukkipati, W.W. O'Neill, K.J. Harjai Characteristics of cerebrovascular accidents after percutaneous coronary interventions J Am Coll Cardiol 43 2004 1161 1167
35. S. Fuchs, E. Stabile, T.D. Kinnaird Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications Circulation 106 2002 86 91
36. C.W. Hogue Jr., S.F. Murphy, K.B. Schechtman, V.G. Dávila- Román Risk factors for early or delayed stroke after cardiac surgery Circulation 100 1999 642 647
37. S.C. Stamou, P.C. Hill, G. Dangas Stroke after coronary artery bypass: incidence, predictors, and clinical outcome Stroke 32 2001 1508 1513
38. D.M. Shahian, S.M. O'Brien, G. Filardo Society of Thoracic Surgeons Quality Measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 - coronary artery bypass grafting surgery Ann Thorac Surg 88 Suppl 1 2009 S2 S22
39. S.J. Connolly, J. Pogue, R.G. Hart ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
40. S. Connolly, J. Pogue, R. Hart ACTIVE Writing Group of the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912